Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1949 1
1963 1
1964 2
1968 2
1969 2
1973 1
1978 4
1979 3
1980 11
1981 9
1982 5
1983 4
1984 10
1985 9
1986 11
1987 12
1988 7
1989 11
1990 12
1991 18
1992 28
1993 19
1994 24
1995 25
1996 24
1997 27
1998 24
1999 22
2000 31
2001 30
2002 35
2003 31
2004 38
2005 39
2006 65
2007 65
2008 51
2009 59
2010 76
2011 67
2012 60
2013 61
2014 88
2015 69
2016 69
2017 87
2018 116
2019 97
2020 93
2021 114
2022 111
2023 128
2024 103
2025 33

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,897 results

Results by year

Filters applied: . Clear all
Page 1
Identification of Structurally Novel KRASG12C Inhibitors through Covalent DNA-Encoded Library Screening.
Huang D, Manoni F, Sun Z, Liu R, Allen JR, Banerjee A, Cee VJ, Eshon J, Frohn MJ, Kaller MR, Lee H, Li C, Li X, Lopez P, Ma V, Medina JM, Mohr C, Mukhina OA, Pickrell AJ, Stellwagen J, Wu W, Zhang W, Zhu K, Dahal UP, Hu LA, Leavitt M, Li W, Li Y, Ma Y, Rex K, Saiki AY, Wang P, Sun Y, Dai D, Tamayo NA, Lanman BA. Huang D, et al. Among authors: lopez p. J Med Chem. 2025 Feb 10. doi: 10.1021/acs.jmedchem.4c03071. Online ahead of print. J Med Chem. 2025. PMID: 39930787
Circulating endothelial progenitor cells and inflammatory markers in type 1 diabetes after an acute session of aerobic exercise.
Bock PM, Monteiro RB, Maraschin CK, Alegretti AP, Farias MG, Spagnol F, Lopez PLDC, Santos LP, Helal L, Moraes RS, Umpierre D, Schaan BD. Bock PM, et al. Among authors: lopez pldc. Arch Endocrinol Metab. 2024 Nov 6;68(Spec Issue):e230499. doi: 10.20945/2359-4292-2023-0499. eCollection 2024. Arch Endocrinol Metab. 2024. PMID: 39876965 Free PMC article.
Association of muscle strength and cardiorespiratory fitness with all-cause and cancer-specific mortality in patients diagnosed with cancer: a systematic review with meta-analysis.
Bettariga F, Galvao D, Taaffe D, Bishop C, Lopez P, Maestroni L, Quinto G, Crainich U, Verdini E, Bandini E, Natalucci V, Newton RU. Bettariga F, et al. Among authors: lopez p. Br J Sports Med. 2025 Jan 21:bjsports-2024-108671. doi: 10.1136/bjsports-2024-108671. Online ahead of print. Br J Sports Med. 2025. PMID: 39837589
Primer Consenso Argentino sobre el manejo del Trastorno por Déficit de Atención e Hiperactividad en la adultez. Primera parte: introducción, metodología de trabajo y generalidades.
Abadi A, Cetkovich-Bakmas M, Klijnjan H, Echavarria N, Lischinsky A, López P, Michanie C, Maresca T, Remedi C, Rovere O, Torrente F, Waisman Campos M, Maraval G, Torralva T, Canseco D, Dellamea A, López Mato A, Vazquez G, Corrales A. Abadi A, et al. Among authors: lopez p. Vertex. 2025 Jan 10;35(166, oct.-dic.):56-84. doi: 10.53680/vertex.v35i166.725. Vertex. 2025. PMID: 39836905 Spanish.
Recommendations on NMOSD treatment in Latin America: Utilizing consensus-based RAND/UCLA methodology.
Alonso R, Rivera V, Carnero Contentti EG, Hamuy Diaz de Bedoya VF, Ciampi E, Silva B, Zuluaga M, Becker J, Rojas JI, Gracia F, Zarco L, Tkachuk V, Molt F, Soto I, Fernandez Calderon R, López P, Patrucco L, Treviño-Frenk I, Sato D, Ramirez D, Navas C, Fujihara K, Galleguillos L. Alonso R, et al. Among authors: lopez p. Mult Scler Relat Disord. 2025 Jan 9;94:106244. doi: 10.1016/j.msard.2024.106244. Online ahead of print. Mult Scler Relat Disord. 2025. PMID: 39823690
Safety and immunogenicity of a bivalent norovirus vaccine candidate in infants from 6 weeks to 5 months of age: A phase 2, randomized, double-blind trial.
Sáez-Llorens X, deAntonio R, López-Medina E, López P, Masuda T, Mendelman PM, Sherwood J, Baehner F, Borkowski A. Sáez-Llorens X, et al. Among authors: lopez p. Hum Vaccin Immunother. 2025 Dec;21(1):2450878. doi: 10.1080/21645515.2025.2450878. Epub 2025 Jan 13. Hum Vaccin Immunother. 2025. PMID: 39803784 Free PMC article. Clinical Trial.
1,897 results